Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2008 2
2010 2
2011 2
2012 3
2013 6
2014 8
2015 3
2016 8
2017 10
2018 11
2019 11
2020 19
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

76 results
Results by year
Filters applied: . Clear all
Page 1
Tumor suppressor ZHX2 inhibits NAFLD-HCC progression via blocking LPL-mediated lipid uptake.
Wu Z, Ma H, Wang L, Song X, Zhang J, Liu W, Ge Y, Sun Y, Yu X, Wang Z, Wang J, Zhang Y, Li C, Li N, Gao L, Liang X, Yue X, Ma C. Wu Z, et al. Cell Death Differ. 2020 May;27(5):1693-1708. doi: 10.1038/s41418-019-0453-z. Epub 2019 Nov 18. Cell Death Differ. 2020. PMID: 31740790 Free PMC article.
Non-alcoholic fatty liver disease (NAFLD) leads to hepatocellular carcinoma (HCC). ...ZHX2 expression was significantly decreased in fatty liver tissues, especially in the liver with NAFLD-HCC. ZHX2 overexpress
Non-alcoholic fatty liver disease (NAFLD) leads to hepatocellular carcinoma (HCC). ...ZHX2 express
Serum zinc level and hepatic fibrosis in patients with nonalcoholic fatty liver disease.
Kim MC, Lee JI, Kim JH, Kim HJ, Cho YK, Jeon WK, Kim BI, Sohn W. Kim MC, et al. PLoS One. 2020 Oct 23;15(10):e0240195. doi: 10.1371/journal.pone.0240195. eCollection 2020. PLoS One. 2020. PMID: 33095789 Free PMC article.
This study aimed to investigate the relationship between serum zinc level and hepatic fibrosis in patients with nonalcoholic fatty liver disease (NAFLD). ...There was an inverse relationship between serum zinc level and FIB-4 index in …
This study aimed to investigate the relationship between serum zinc level and hepatic fibrosis in patients with nonalcoholic fatty
Zinc-alpha2-glycoprotein 1 attenuates non-alcoholic fatty liver disease by negatively regulating tumour necrosis factor-alpha.
Liu T, Luo X, Li ZH, Wu JC, Luo SZ, Xu MY. Liu T, et al. World J Gastroenterol. 2019 Sep 28;25(36):5451-5468. doi: 10.3748/wjg.v25.i36.5451. World J Gastroenterol. 2019. PMID: 31576092 Free PMC article.
The underlying molecular mechanisms and therapeutic effects of AZGP1 remain unknown in non-alcoholic fatty liver disease (NAFLD). AIM: To explore the effects and potential mechanism of AZGP1 on NAFLD in vivo and in vitro. ...Finall …
The underlying molecular mechanisms and therapeutic effects of AZGP1 remain unknown in non-alcoholic fatty liver
Zinc and Selenium Co-supplementation Reduces Some Lipid Peroxidation and Angiogenesis Markers in a Rat Model of NAFLD-Fed High Fat Diet.
Mousavi SN, Faghihi A, Motaghinejad M, Shiasi M, Imanparast F, Amiri HL, Shidfar F. Mousavi SN, et al. Biol Trace Elem Res. 2018 Feb;181(2):288-295. doi: 10.1007/s12011-017-1059-2. Epub 2017 Jun 2. Biol Trace Elem Res. 2018. PMID: 28577233
Studies have shown that non-alcoholic fatty liver disease (NAFLD) patients are more prone to cardiovascular disease (CVD). Zinc and selenium deficiency are common in NAFLD. But the effects of zinc and selenium …
Studies have shown that non-alcoholic fatty liver disease (NAFLD) patients are more prone to cardi …
Orlistat-associated adverse effects and drug interactions: a critical review.
Filippatos TD, Derdemezis CS, Gazi IF, Nakou ES, Mikhailidis DP, Elisaf MS. Filippatos TD, et al. Drug Saf. 2008;31(1):53-65. doi: 10.2165/00002018-200831010-00005. Drug Saf. 2008. PMID: 18095746 Review.
A few cases of serious hepatic adverse effects (cholelithiasis, cholostatic hepatitis and subacute liver failure) have been reported. However, the effects of orlistat on non-alcoholic fatty liver disease are beneficial. ...No effect has b …
A few cases of serious hepatic adverse effects (cholelithiasis, cholostatic hepatitis and subacute liver failure) have been reported. …
Zinc Supplementation Alleviates Lipid and Glucose Metabolic Disorders Induced by a High-Fat Diet.
Qi Y, Zhang Z, Liu S, Aluo Z, Zhang L, Yu L, Li Y, Song Z, Zhou L. Qi Y, et al. J Agric Food Chem. 2020 May 6;68(18):5189-5200. doi: 10.1021/acs.jafc.0c01103. Epub 2020 Apr 24. J Agric Food Chem. 2020. PMID: 32290656
High zinc can reduce glucose production, promote glucose absorption, reduce lipid deposition, improve HFD-induced liver injury, and regulate energy metabolism. This study provides novel insight into the treatment of non-alcoholic fatty liver
High zinc can reduce glucose production, promote glucose absorption, reduce lipid deposition, improve HFD-induced liver injury …
Non-linear association of serum molybdenum and linear association of serum zinc with nonalcoholic fatty liver disease: Multiple-exposure and Mendelian randomization approach.
Li L, Huang L, Huang S, Luo X, Zhang H, Mo Z, Wu T, Yang X. Li L, et al. Sci Total Environ. 2020 Jun 10;720:137655. doi: 10.1016/j.scitotenv.2020.137655. Epub 2020 Feb 29. Sci Total Environ. 2020. PMID: 32146412
The homeostasis imbalance of metals is closely associated with nonalcoholic fatty liver disease (NAFLD). A total of 1594 and 566 Chinese Han men were enrolled in cross-sectional and longitudinal analyses, respectively. ...In MR analysis, no causal asso …
The homeostasis imbalance of metals is closely associated with nonalcoholic fatty liver disease (NAFLD). A total …
Zinc oxide nanoparticles attenuate hepatic steatosis development in high-fat-diet fed mice through activated AMPK signaling axis.
Dogra S, Kar AK, Girdhar K, Daniel PV, Chatterjee S, Choubey A, Ghosh S, Patnaik S, Ghosh D, Mondal P. Dogra S, et al. Nanomedicine. 2019 Apr;17:210-222. doi: 10.1016/j.nano.2019.01.013. Epub 2019 Jan 30. Nanomedicine. 2019. PMID: 30708053
Insulin resistance is thought to be a common link between obesity and Non-Alcoholic Fatty Liver Disease (NAFLD). NAFLD has now reached epidemic status worldwide and identification of molecules or pathways as newer therapeutic strat …
Insulin resistance is thought to be a common link between obesity and Non-Alcoholic Fatty Liver Disease ( …
The Effect of Zinc Supplementation on Steatosis Severity and Liver Function Enzymes in Overweight/Obese Patients with Mild to Moderate Non-alcoholic Fatty Liver Following Calorie-Restricted Diet: a Double-Blind, Randomized Placebo-Controlled Trial.
Fathi M, Alavinejad P, Haidari Z, Amani R. Fathi M, et al. Biol Trace Elem Res. 2020 Oct;197(2):394-404. doi: 10.1007/s12011-019-02015-8. Epub 2020 Feb 4. Biol Trace Elem Res. 2020. PMID: 32020523
Fifty-six overweight/obese subjects with confirmed non-alcoholic fatty liver disease (NAFLD) using ultrasonography were randomized to treatment (calorie-restricted diet plus 30 mg/day zinc supplement) or placebo (calorie-restricted …
Fifty-six overweight/obese subjects with confirmed non-alcoholic fatty liver disease (NAFLD) using …
Zinc alpha2 glycoprotein protects against obesity-induced hepatic steatosis.
Xiao XH, Wang YD, Qi XY, Wang YY, Li JY, Li H, Zhang PY, Liao HL, Li MH, Liao ZZ, Yang J, Xu CX, Wen GB, Liu JH. Xiao XH, et al. Int J Obes (Lond). 2018 Aug;42(8):1418-1430. doi: 10.1038/s41366-018-0151-9. Epub 2018 Jul 13. Int J Obes (Lond). 2018. PMID: 30006580
BACKGROUND/AIM: Nonalcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis, impaired insulin sensitivity, and chronic low-grade inflammation. ...The molecular mechanisms underlying ZAG-regulated hepatic steatosis were further explor …
BACKGROUND/AIM: Nonalcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis, impaired insulin …
76 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page